Capital Rx secures $106 million in Series C funding

Capital Rx is an American health tech platform that provides pharmacy benefit management solutions. Provides an enterprise pharmacy platform that digitally links providers, patients, pharmacies. Since its inception, the company has grown to serve thousands of members and process millions of prescriptions each year. Recently announced a $106 million Series C round led by B Capital, with participation from General Catalyst and existing investors Edison Partners and Transformation Capital.

This article is reproduced from: https://www.itjuzi.com/investevent/13278736
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment